An 11-year retrospective review of venlafaxine ingestion in children from the California Poison Control System

Human & Experimental Toxicology
S DoroudgarT E Albertson

Abstract

Venlafaxine is commonly used in the United States for approved and non-Food and Drug Administration-approved indications in adults. It is used off-label to treat children for psychiatric diagnoses. The aim of the study was to describe venlafaxine toxicities in children and to identify the venlafaxine dose per weight that correlates with toxicities. An 11-year retrospective study of venlafaxine ingestion in children was performed using the California Poison Control System (CPCS) database. Data was extracted from phone calls received by CPCS clinicians and follow-up phone calls made to assess the patient's progress in a health-care setting. Inclusion criteria were venlafaxine ingestion cases reported to CPCS between January 2001 and December 2011, children aged 20 years and under, venlafaxine as the only ingested substance, managed in a health-care facility, and followed to a known outcome. Two hundred sixty-two cases met the study criteria. Common presentations included gastrointestinal (14.9%), altered mental status (13.7%), and tachycardia (13.4%). The majority of the cases resulted in no effect (51.5%) or minor effect (19.9%). The average estimated dose per weight was 18.3 mg/kg in all patients and 64.5 mg/kg in those experie...Continue Reading

References

Jul 1, 1996·Journal of Analytical Toxicology·A T ParsonsJ E Meeker
Oct 1, 1996·Journal of Analytical Toxicology·B LevineJ E Smialek
Mar 1, 1997·Journal of Analytical Toxicology·C LongS Teas
Nov 5, 2002·Human & Experimental Toxicology·J J OliverD N Bateman
Jan 7, 2004·Journal of Toxicology. Clinical Toxicology·G Randall BondDonald R A Uges
Apr 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Sharon RatnerPaz Toren
Nov 24, 2005·The American Journal of Forensic Medicine and Pathology·Martin W Shaw, Jonathan D H Sheard
Feb 15, 2007·British Journal of Clinical Pharmacology·C HowellW S Waring
Mar 26, 2008·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Jonas HöjerHeléne Salmonson
Jun 12, 2009·The Journal of Emergency Medicine·Ignacio García-CabezaManuel González de Chávez
May 11, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Marian ChristophSteffen Schön
Jul 20, 2010·Clinical Cardiology·Rajesh Sachdeva
Apr 13, 2011·Developmental Psychobiology·Margaret C MoulsonCharles A Nelson
Jan 19, 2012·Journal of Child and Adolescent Psychopharmacology·Karen Dineen WagnerDavid Brent

❮ Previous
Next ❯

Citations

Jun 5, 2018·International Journal of Toxicology·Melad G PaulisMohmed K M Aly
Jan 3, 2021·Pediatrics in Review·David C SheridanB Zane Horowitz

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Human & Experimental Toxicology
A L Lofton, Wendy Klein-Schwartz
The American Journal of Emergency Medicine
S David Baker, D L Morgan
Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists
J C LewisJ B Ford
© 2021 Meta ULC. All rights reserved